Human BRCA1 C-Terminus Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | AF6955SP-Each-of-1 | In Stock | ₹ 17,844.50 |
AF6955SP - Each of 1
In Stock
Quantity
1
Base Price: ₹ 17,844.50
GST (18%): ₹ 3,212.01
Total Price: ₹ 21,056.51
Antigen
BRCA1
Classification
Polyclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
Gene Alias
BRCAI, breast and ovarian cancer susceptibility protein 1, breast and ovarian cancer sususceptibility protein, breast cancer 1, early onset, breast cancer type 1 susceptibility protein, EC 6.3.2, EC 6.3.2.-, IRIS, PNCA4, PSCP, subunit 1
Host Species
Sheep
Purification Method
Affinity Purified
Regulatory Status
RUO
Gene ID (Entrez)
672
Reconstitution
Sterile PBS to a final concentration of 0.2 mg/mL.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Applications
Immunohistochemistry
Concentration
LYOPH
Dilution
Immunohistochemistry 5-15 ug/mL
Gene Accession No.
P38398
Gene Symbols
BRCA1
Immunogen
E. coli-derived recombinant human BRCA1 C-Terminus Arg1634-Tyr1863 Accession # P38398
Quantity
25 μg
Primary or Secondary
Primary
Test Specificity
Detects human BRCA1 C-Terminus in direct ELISAs.
Target Species
Human
Isotype
IgG
Related Products
Description
- BRCA1 Polyclonal specifically detects BRCA1 in Human samples
- It is validated for Immunohistochemistry.